TRIDENT Preclinical Trials
@tridentpct.bsky.social did:plc:vouye45hmnqbrpky74lqvk6f
Multi-site, transformative preclinical evaluation of novel neurotherapeutics through a Government of Canada $24M New Frontiers In Research grant. Check out our website tridentpreclinicaltrials.org for more info or email [email protected]!
Bluesky’a katılma tarihi:
- Takipçi
- 1.443
- Takip edilen
- 9.907
- Post
- 432
- Sıralamaya girdiği gün
- 0
Özet
TRIDENT Preclinical Trials (@tridentpct.bsky.social), 8 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 1.443 takipçisi var, 9.907 hesabı takip ediyor ve 432 post paylaştı.
Sıralama geçmişi
Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.
Bu hesap henüz günlük sıralamaya girmedi.
Son beğendiği postlar
Bluesky ağındaki herkese açık beğeniler.
A fantastic week @touchscreencog.bsky.social with two papers that are part of our larger collaborations accepted and a visit by @malutansey.bsky.social who gave us a master class of immunology responses in Alzheimer’s and Parkinson’s disease. It invigorated @tridentpct.bsky.social to push harder
Postu gösterThis paper, co-authored with Saher Panjwani, is part of the EJPS topical collection on The Pursuitworthiness of Experiments Across the Sciences edited by @ennofischer.bsky.social and @alejandrofabregastejeda.com. #philsci
Postu gösterone of the advantages of working on @tridentpct.bsky.social is to interact with great collaborators like Tom Durcan at @theneuro.bsky.social to help stain and image with light sheet 🔬 their organoids (TH red and GFAP blue) used to test new drugs for Parkinson’s Disease
Postu göster#fluorescencefriday NeuN (gray) and nuclei (red) from the @mind-western.bsky.social team
Postu göster
Blokladığı hesaplar
Bluesky’da bloklar herkese açık kayıtlardır.
